These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 34278936)
1. Evaluating the utility of therapeutic drug monitoring in the clinical use of small molecule kinase inhibitors: a review of the literature. Fahmy A; Hopkins AM; Sorich MJ; Rowland A Expert Opin Drug Metab Toxicol; 2021 Jul; 17(7):803-821. PubMed ID: 34278936 [No Abstract] [Full Text] [Related]
2. Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure. Rowland A; van Dyk M; Mangoni AA; Miners JO; McKinnon RA; Wiese MD; Rowland A; Kichenadasse G; Gurney H; Sorich MJ Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):31-49. PubMed ID: 27561659 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review. Cardoso E; Guidi M; Blanchet B; Schneider MP; Decosterd LA; Buclin T; Csajka C; Widmer N Ther Drug Monit; 2020 Feb; 42(1):33-44. PubMed ID: 31479043 [TBL] [Abstract][Full Text] [Related]
4. A framework for economic evaluation of therapeutic drug monitoring-guided dosing in oncology. Erku D; Schneider J; Scuffham P Pharmacol Res Perspect; 2021 Oct; 9(5):e00862. PubMed ID: 34546005 [TBL] [Abstract][Full Text] [Related]
5. Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology. Verheijen RB; Yu H; Schellens JHM; Beijnen JH; Steeghs N; Huitema ADR Clin Pharmacol Ther; 2017 Nov; 102(5):765-776. PubMed ID: 28699160 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Targets for Therapeutic Drug Monitoring of Small Molecule Kinase Inhibitors in Pediatric Oncology. Janssen JM; Dorlo TPC; Steeghs N; Beijnen JH; Hanff LM; van Eijkelenburg NKA; van der Lugt J; Zwaan CM; Huitema ADR Clin Pharmacol Ther; 2020 Sep; 108(3):494-505. PubMed ID: 32022898 [TBL] [Abstract][Full Text] [Related]
7. A novel approach for the simultaneous quantification of 18 small molecule kinase inhibitors in human plasma: A platform for optimised KI dosing. van Dyk M; Miners JO; Kichenadasse G; McKinnon RA; Rowland A J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():17-26. PubMed ID: 27521531 [TBL] [Abstract][Full Text] [Related]
8. Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine. Groenland SL; Mathijssen RHJ; Beijnen JH; Huitema ADR; Steeghs N Eur J Clin Pharmacol; 2019 Sep; 75(9):1309-1318. PubMed ID: 31175385 [TBL] [Abstract][Full Text] [Related]
9. Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies. Widmer N; Bardin C; Chatelut E; Paci A; Beijnen J; Levêque D; Veal G; Astier A Eur J Cancer; 2014 Aug; 50(12):2020-36. PubMed ID: 24928190 [TBL] [Abstract][Full Text] [Related]
10. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity. Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644 [TBL] [Abstract][Full Text] [Related]
11. Applications and challenges in therapeutic drug monitoring of cancer treatment: A review. Salman B; Al-Khabori M J Oncol Pharm Pract; 2021 Apr; 27(3):693-701. PubMed ID: 33302823 [TBL] [Abstract][Full Text] [Related]
12. Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets. Yu H; Steeghs N; Nijenhuis CM; Schellens JH; Beijnen JH; Huitema AD Clin Pharmacokinet; 2014 Apr; 53(4):305-25. PubMed ID: 24566736 [TBL] [Abstract][Full Text] [Related]
13. [Role of individualized dosing in oncology: are we there yet?]. Joerger M Praxis (Bern 1994); 2013 Dec; 103(1):33-9. PubMed ID: 24393821 [TBL] [Abstract][Full Text] [Related]
14. On precision dosing of oral small molecule drugs in oncology. Lyashchenko AK; Cremers S Br J Clin Pharmacol; 2021 Feb; 87(2):263-270. PubMed ID: 32621551 [TBL] [Abstract][Full Text] [Related]
15. From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics. Wicha SG; Märtson AG; Nielsen EI; Koch BCP; Friberg LE; Alffenaar JW; Minichmayr IK; Clin Pharmacol Ther; 2021 Apr; 109(4):928-941. PubMed ID: 33565627 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of oral targeted antineoplastic drugs. Mueller-Schoell A; Groenland SL; Scherf-Clavel O; van Dyk M; Huisinga W; Michelet R; Jaehde U; Steeghs N; Huitema ADR; Kloft C Eur J Clin Pharmacol; 2021 Apr; 77(4):441-464. PubMed ID: 33165648 [TBL] [Abstract][Full Text] [Related]
17. Current status and future outlooks on therapeutic drug monitoring of fluorouracil. Schmulenson E; Zimmermann N; Mikus G; Joerger M; Jaehde U Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1407-1422. PubMed ID: 35029518 [TBL] [Abstract][Full Text] [Related]
18. The past, present, and future of chemotherapy with a focus on individualization of drug dosing. DeRidder L; Rubinson DA; Langer R; Traverso G J Control Release; 2022 Dec; 352():840-860. PubMed ID: 36334860 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring in cancer--are we missing a trick? Bardin C; Veal G; Paci A; Chatelut E; Astier A; Levêque D; Widmer N; Beijnen J Eur J Cancer; 2014 Aug; 50(12):2005-9. PubMed ID: 24878063 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic Drug Monitoring of Protein Kinase Inhibitors in the Treatment of Non-small Cell Lung Cancer. Staša J; Gregorová J; Slanař O; Šíma M Prague Med Rep; 2023; 124(3):199-215. PubMed ID: 37736945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]